SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Coull MA, Lowther S, Katona CL, Horton RW. Eur. Neuropsychopharmacol. 2000; 10(4): 283-288.

Copyright

(Copyright © 2000, Elsevier Publishing)

DOI

10.1016/s0924-977x(00)00084-5

PMID

10871711

Abstract

[(3)H]Phorbol 12,13-dibutyrate (PDBu) binding was measured in soluble and particulate fractions of frontal cortex and hippocampus from suicides, with a firm retrospective diagnosis of depression, and individually matched controls. Suicides were divided into those who had been free of antidepressant drugs for at least 3 months and those in whom prescription of antidepressants was clearly documented. In frontal cortex, there was a significantly higher number (by 75%) of [(3)H]PDBu binding sites in the soluble fraction in antidepressant-free suicides compared to controls; significant differences were also seen in the proportion of sites in the soluble and particulate fractions. Higher numbers of [(3)H]PDBu binding sites in the particulate fraction of hippocampus in antidepressant-free suicides was restricted to those who died by violent means. No significant differences in the number of [(3)H]PDBu binding sites were found in antidepressant-treated suicides compared to controls. This study provides evidence for the involvement of protein kinase C in the pathophysiology of depression.


Language: en

Keywords

Humans; Female; Male; Suicide; Postmortem Changes; Binding Sites; Antidepressive Agents/pharmacology; Depression/*enzymology; Hippocampus/*enzymology; Phorbol 12,13-Dibutyrate/pharmacology; Prefrontal Cortex/enzymology; Protein Kinase C/*analysis

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print